What we do.

Tried and Tested Approach

PILOT LITE CAPITAL BENEFITS FROM ITS UNIQUE ASSOCIATION WITH ITS VENTURE SERVICE PARTNER

The Venture Services and Capital division are at the forefront of venture commercialisation, with over a 10 year track record of successfully maximising the value of stranded R&D assets for some of the world’s largest companies in the FMCG (CPG) Food & beverage, Consumer Health, Nutrition, Pharma, Medtech and Oil & Gas sectors

PLV HAS A SUBSTANTIAL EXISTING PIPELINE FOR ITS CAPITAL BUSINESS:

PLV has originated an exclusive, off-market pipeline with global multinationals to acquire and fund R&D projects in order to then bring them to market on an accelerated and de-risked basis.

EXPERIENCED VENTURE MANAGEMENT:

Pilot Lite Capital deploys a unique turn-key venture management solution that PLV has developed and refined over the last 10 years to validate and commercialize corporate R&D projects for accelerated and de-risked launch, deploying Pilot Lite Capital’s co-investment as required

VENTURE SERVICES AND CAPITAL INVESTMENT LEVELS

£1m for immediate seed investment to get the R&D opportunity immediately staffed and processes deployed outside the corporate and then follow up to £3m-£5m for round 1 and round 2 £15-£20m

OUTCOME FOR CORPORATES

The Unique hybrid Venture Management process of Venture Services and Capital:
  • Turn key incubation platform for adjacent R&D projects
  • De-risked launch of proven products and technologies, aligned to a corporate category and brand objectives – ready for scale
  • Material improvements on R&D ROI, less waste of time and resources
  • Significantly more cost-effective innovation growth than open market acquisition of technologies

Why do corporates need the end to end solution?

PLV’s established platform has proven that commercialisation of R&D outside of the Corporate accelerates as well as maximises its value.

CORPORATE CHALLENGE

Global corporates often lack the internal expertise, management bandwidth and/or divisional budget (in particular in light of continuing internal capital allocation challenges and the impact of zero-based budgeting) to translate all the opportunities that they hold into valuable businesses

Over $2tn is the estimated opportunity cost to the top 1,000 global corporations of stranded R&D projects over a five year period

WHAT ARE THE CORPORATES DOING

In an effort to overcome these obstacles and harness the potential of these stranded opportunities, global corporations are radically re-evaluating their approach to the commercialisation of R&D. To maximise ROI, they need to joint venture or spin out R&D projects in ways not previously considered. This is generating a disruptive opportunity to create a new institutional-scale asset class in corporate R&D

WHAT WE LOOK FOR

PLC will focus on Corporate Technology Readiness Level (TRL) 3 & 4+